日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The right glucarpidose?

正确的葡糖醛酸?

Heerma van Voss, Marise R; Sikma, Maaike A; Engels, Frederike K; Rijneveld, Anita W; Dijkman, Marieke A; Koppen, Arjen; Chamuleau, Martine E D; Bartelink, Imke H

Pharmacokinetic and pharmacodynamic evaluation of alternative pomalidomide dosing regimens in the treatment of multiple myeloma

多发性骨髓瘤治疗中泊马度胺替代给药方案的药代动力学和药效学评价

Seefat, M R; Cucchi, D G J; van Boven, L; Durdu-Rayman, N; Groen, K; Levin, M-D; de Heer, K; de Valk, B; Wester, R; van der Spek, E; Rentenaar, R; Korst, C L B M; Quik, M; O'Neill, C A; Tzortzi, P; Smits, F; Mathot, R; Heerma van Voss, M R; van de Donk, N W C J; Mutis, T; Bartelink, I H; Zweegman, S

Restrictive versus standard hyperhydration during high-dose cyclophosphamide for hematopoietic stem cell transplantation: a retrospective cohort study

造血干细胞移植期间高剂量环磷酰胺治疗中限制性与标准性水化:一项回顾性队列研究

Boosman, R J; Chan, R M; Nur, E; Huls, H J; Crul, M; Heerma van Voss, M R

Inhibition of DDX3 modulates immune signaling in aggressive breast cancers

抑制DDX3可调节侵袭性乳腺癌中的免疫信号传导

Vesuna, Farhad; Winnard, Paul T Jr; van Voss, Marise Heerma; Bol, Guus M; Ter Hoeve, Natalie D; van Diest, Paul J; Raman, Venu

Model-Informed Precision Dosing of Busulfan for Children and Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Critical Evaluation of Current PK Models and Dose Recommendations

基于模型指导的白消安精准给药在接受异基因造血干细胞移植的儿童和成人中的应用:对现有药代动力学模型和剂量建议的批判性评价

Mahomedradja, Rashudy F; Bognàr, Tim; van Schie, Kaj E; Kuipers, Ilse T; de Witte, Moniek A; Kuball, Jurgen H E; Nur, Erfan; Wilhelm, Bram J; Heerma van Voss, Marise R; Franken, Linda; Lalmohamed, Arief; Swart, Eleonora Noortje L; de Leeuw, Dave C; Bartelink, Imke H

Debiasing training reduces confirmation bias in national risk analysts

消除偏见的培训可以减少国家风险分析师的确认偏见。

Heerma van Voss, Bas; Yoon, Haewon; Scopelliti, Irene; Zweet, Rowena; Helsloot, Ira; Morewedge, Carey K

A Drop of Blood to Lead the Way

一滴血指引方向

Claushuis, Theodora A M; Wondergem, Marielle J; Beverloo, Henriette B; Heerma van Voss, Marise R; Molenaar, Remco J; Zwolsman, Maud; van der Valk, Fleur M; Mooij, Hans L; Koens, Lianne; Tonino, Sanne H

A sub-pharmacological test dose does not predict individual docetaxel exposure in prostate cancer patients

亚药理剂量试验并不能预测前列腺癌患者个体多西他赛暴露量。

Heerma van Voss, Marise R; Notohardjo, Jessica; van Dodewaard-de Jong, Joyce; Bloemendal, Haiko J; Ter Heine, Rob

Targeting mitochondrial translation by inhibiting DDX3: a novel radiosensitization strategy for cancer treatment

通过抑制 DDX3 靶向线粒体翻译:一种用于癌症治疗的新型放射增敏策略

M R Heerma van Voss, F Vesuna, G M Bol, J Afzal, S Tantravedi, Y Bergman, K Kammers, M Lehar, R Malek, M Ballew, N Ter Hoeve, D Abou, D Thorek, C Berlinicke, M Yazdankhah, D Sinha, A Le, R Abrahams, P T Tran, P J van Diest, V Raman

Global Effects of DDX3 Inhibition on Cell Cycle Regulation Identified by a Combined Phosphoproteomics and Single Cell Tracking Approach

通过磷酸化蛋白质组学和单细胞追踪方法鉴定 DDX3 抑制对细胞周期调控的整体影响

Marise R Heerma van Voss, Kai Kammers, Farhad Vesuna, Justin Brilliant, Yehudit Bergman, Saritha Tantravedi, Xinyan Wu, Robert N Cole, Andrew Holland, Paul J van Diest, Venu Raman